2025-08-08 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc. (TDOC) based on the provided data.

**Report: Teladoc Health Inc. (TDOC) Analysis**

Teladoc Health Inc. provides virtual healthcare services, connecting patients with doctors remotely.

**1. Performance vs. S&P 500 (VOO)**

*   **TDOC Cumulative Return:** -70.06%
*   **VOO Cumulative Return:** 82.59%
*   **Absolute Deviation:** -165.3%
*   **Relative Deviation:** 1.1 (Indicates TDOC is currently near its lowest relative performance compared to VOO over the historical period.)

**Analysis:** TDOC has significantly underperformed the S&P 500 (VOO). The substantial negative deviation suggests significant challenges in TDOC's performance relative to the broader market.  A relative deviation of 1.1 implies TDOC is performing near the lower end of its historical performance range compared to the index.

**Alpha, Beta Analysis Table:**

| Year       | CAGR   | MDD    | Alpha    | Beta   | Cap(B) |
| ---------- | ------ | ------ | -------- | ------ | ------ |
| 2015-2017  | 3.0%   | 3.3%   | 0.0%     | 0.5    | 6.2    |
| 2016-2018  | 28.0%  | 58.8%  | 33.0%    | 0.0    | 8.8    |
| 2017-2019  | 98.0%  | 58.8%  | 76.0%    | 0.0    | 14.8   |
| 2018-2020  | 181.0% | 63.8%  | 154.0%   | 0.0    | 35.3   |
| 2019-2021  | -43.0% | 63.8%  | -92.0%   | 0.0    | 16.2   |
| 2020-2022  | -195.0%| 81.3%  | -202.0%  | -0.0   | 4.2    |
| 2021-2023  | -330.0%| 81.3%  | -351.0%  | -0.8   | 3.8    |
| 2022-2024  | -74.0% | 81.3%  | -101.0%  | -1.0   | 1.6    |
| 2023-2025  | -23.0% | 75.4%  | -71.0%   | -0.4   | 1.2    |

**Analysis:**

*   **CAGR & MDD:** The table shows a dramatic decline in CAGR (Compound Annual Growth Rate) over recent periods, along with high MDD (Maximum Drawdown), indicating significant losses and volatility.
*   **Alpha:** Alpha is consistently negative in recent years, meaning TDOC has underperformed its benchmark even after accounting for market risk.
*   **Beta:** Beta fluctuates and is sometimes negative, suggesting the stock's price is not strongly correlated with the market.
*   **Cap(B):** Market capitalization has decreased significantly, reflecting the company's declining valuation.

**2. Recent Stock Price Movement**

*   **Current Price:** 6.95
*   **Previous Close:** 6.99
*   **Change:** -0.57%
*   **5-Day Moving Average:** 6.962
*   **20-Day Moving Average:** 7.7675
*   **60-Day Moving Average:** 7.6055

**Analysis:** The stock is currently trading below its 5, 20, and 60-day moving averages, suggesting a short-term downtrend. The slight decrease in price from the previous close (-0.57%) is relatively minor but contributes to the overall negative trend.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.3318 (Low Risk)
*   **RSI:** 25.88 (Oversold)
*   **PPO:** -1.95 (Negative)
*   **Hybrid Signal:** cash_69%_Sell 1.0% of holdings (14 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Deviation Change:** 1.1 (Positive - Short-term Increase)
*   **Expected Return (%):** -10136.4%

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a low-risk environment.
*   **RSI:** The RSI indicates that the stock is oversold, which might suggest a potential for a price rebound.
*   **PPO:** A negative PPO suggests that the short-term moving average is below the long-term moving average, confirming the downtrend.
*   **Hybrid Signal:** The hybrid signal recommends holding a significant cash position and selling a small portion of the holdings, reflecting caution.
*   **Recent Relative Deviation Change:** The recent positive change in relative deviation suggests a short-term upward movement, but the overall deviation remains significantly negative.
*   **Expected Return (%):** The extremely negative expected return is a strong red flag, indicating significant expected underperformance compared to the S&P 500 over the long term.
*   **price, previousClose, change**: The fact that the current closing price is less than the previousClose indicates a downward trend.

**4. Recent News & Significant Events:**

*   **[2025-08-05]:** Major business developments, regulatory changes, or market events.
*   **[2025-08-04]:** Analysts discussing performance and outlook.
*   **[2025-08-07]:** Notable stock volatility.
*   **[2025-08-08]:** Market experts highlighting risks and opportunities.

**Analysis:** Recent news indicates significant events impacting the company, analyst discussions about performance, and notable stock volatility. Investors should monitor these developments closely.

**5. Recent Earnings Analysis:**

| 날짜       | EPS   | 매출      |
| ---------- | ----- | --------- |
| 2025-07-30 | -0.19 | 0.63 B$   |
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2025-07-30 | -4.92 | 0.64 B$   |

**Analysis:**  The EPS (Earnings Per Share) has been negative in recent quarters, indicating unprofitability. The revenue has remained relatively stable, but the consistent losses raise concerns about the company's financial health.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
| ---------- | ------- | ------------- |
| 2025-06-30 | $0.63B  | 69.85%        |
| 2025-03-31 | $0.63B  | 68.73%        |
| 2024-12-31 | $0.64B  | 70.50%        |
| 2024-09-30 | $0.64B  | 71.94%        |
| 2024-06-30 | $0.64B  | 70.73%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
| ---------- | --------- | --------- |
| 2025-06-30 | $1.42B    | -2.30%    |
| 2025-03-31 | $1.43B    | -6.52%    |
| 2024-12-31 | $1.49B    | -3.25%    |
| 2024-09-30 | $1.51B    | -2.21%    |
| 2024-06-30 | $1.50B    | -55.77%   |

**Analysis:**

*   **Revenue:**  Revenue has been relatively consistent around $0.63-0.64B per quarter.
*   **Profit Margin:** Profit margins are relatively high.
*   **Equity:** Equity has slightly decreased, indicating a potential decline in the company's net worth.
*   **ROE:** The negative ROE (Return on Equity) values reflect the company's inability to generate profits from shareholders' investments.

**7. Overall Analysis:**

Teladoc Health Inc. (TDOC) exhibits several concerning factors:

*   **Underperformance:** Significant underperformance compared to the S&P 500, with a large negative absolute deviation.
*   **Deteriorating Financials:** Negative EPS, negative ROE, and decreasing equity raise concerns about the company's profitability and financial health.
*   **Downtrend:** The stock is in a short-term downtrend, trading below its moving averages.
*   **Negative Outlook:** The extremely negative expected return indicates a pessimistic long-term outlook.

**Recommendation:**

Based on the current analysis, a highly cautious approach is warranted. The company faces significant challenges and shows limited signs of recovery. While the stock might be oversold in the short term, the underlying financial issues and negative outlook suggest substantial risks. Investors should closely monitor the company's progress and consider alternative investment opportunities.

